Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy

International Journal of Clinical Oncology

Volumn 20, Issue 1, 2015, Pages 176-181

  Koie, Takuya ^a   Mitsuzuka, Koji ^b   Yoneyama, Takahiro ^a   Narita, Shintaro ^c   Kawamura, Sadafumi ^d   Kaiho, Yasuhiro ^b   Tsuchiya, Norihiko ^c   Tochigi, Tatsuo ^d   Habuchi, Tomonori ^c   Arai, Yoichi ^b   Ohyama, Chikara ^a   Yoneyama, Tohru ^a   Tobisawa, Yuki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Miyagi Cancer Center   (Japan)

Author keywords

Advanced prostate cancer; Biochemical recurrence free survival; High risk; Prostate cancer; Prostate specific antigen density

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; BIOPSY; CANCER GRADING; DISEASE FREE SURVIVAL; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; RISK; SURVIVAL RATE;

AGED; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK; SURVIVAL RATE;

EID: 84939894600     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0696-0     Document Type: Article

References (21)

1. D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974
2. Yuh B, Artibani W, Heidenreich et al (2013) The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. Eur Urol. doi:10.1016/j.eururo.2013.05.026
3. Loeb S, Schaeffer EM, Trock BJ et al (2010) What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology 76:710–714
4. Sundi D, Wang V, Pierorazio PM et al (2014) Identification of men with the highest risk of early disease recurrence after radical prostatectomy. Prostate. doi:10.1002/pros.22780
5. Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery-what have learned and where we are going. J Urol 162:293–306
6. Horiguchi A, Nakashima J, Horiguchi Y et al (2003) Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Prostate 56:23–29
7. Brassell SA, Kao T, Sun L et al (2005) Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer. Urology 66:1229–1233
8. Corn BW, Hanks GE, Lee WR et al (1995) Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy. J Urol 153:1855–1859
9. American Joint Committee on Cancer (AJC) (2010) Prostate. In: Edge SB, Byrd DR, Compton CC et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 457–468
10. Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228–1242
11. Gancarczyk KJ, Wu H, McLeod DG et al (2003) Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology 61:589–595
12. Perkins NJ, Schisterman EF (2006) The inconsistency of ‘optimal’ cutpoints obtained using two criteria based on the receiver operating characteristics curve. Am J Epidemiol 163:670–675
13. Boorjian SA, Karnes RJ, Rangel LJ et al (2008) Mayo clinic validation of the D’Amico risk group classification for predicting survival following radical prostatectomy. J Urol 179:1354–1361
14. Ishida M, Nakashima J, Hashiguchi A et al (2009) Are predictive models for cancer volume clinically useful in localized prostate cancer? Int J Urol 16:936–940
15. Lee JT, Lee S, Yun CJ et al (2010) Prediction of perineural invasion and its prognostic value in patients with prostate cancer. Korean J Urol 51:745–751
16. Pierorazio PM, Guzzo TJ, Han M et al (2010) Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology 76:715–721
17. Koie T, Hashimoto Y, Hatakeyama S et al (2011) Minimum incision endoscopic radical prostatectomy: clinical and oncological outcomes at a single institute. Eur J Surg Oncol 37:805–810
18. Tsuzuki T, Hernandez DJ, Aydin H et al (2005) Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination. J Urol 173:450–453
19. Perotti M, Pantuck A, Rabbani F et al (1999) Review of staging modalities in clinically localized prostate cancer. Urology 54:208–214
20. Radwan MH, Yan Y, Luly JR et al (2007) Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology 69:1121–1127
21. Giannarini G, Scott CA, Moro U et al (2008) Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinical localized prostate cancer? Urol Oncol 26:353–360